Table 2

Medtronic CoreValve Transcatheter Heart Valve Registries

CharacteristicTamburino et al. (109) (N=663)Milan (107) (N=61)French (106) (N=66)Spanish (97) (N=108)UK/Ireland (108) (N=288)UK (115) (N=452)German (110) (N=588)Buellesfeld et al. (105) (N=126)
Demographics
Age (y)827982.578.68181.381.481.9
Female (%)564751.554.6NR4855.857.1
EuroSCORE (mean, %)2326.624.7162218.120.823.4
NYHA functional class III/IV (%)71.56974.658.47473.988.274.6
Mean gradient (mm Hg)52544655NRNR48.746.8
Outcomes
Procedural success (%)9898.492.698.197.598.2NR72.6
30-day mortality (%)5.92.215.17.44.75.812.415.2
1-y mortality (%)1518.4NR17.7NR21.7NR38.1⁎⁎
Stroke (%)2.52.24.50.04.24.02.8NR
Major vascular complications (%)2.021.37.55.69.06.24.0NR
Permanent pacemaker (%)19.126.125.735.22624.442.526.2

N indicates number; NR, not reported; and NYHA, New York Heart Association.

  • 6-month survival,

  • ⁎⁎ 2-year survival.